Crescita Therapeutics Inc. (TSX: CTX)

Crescita Therapeutics Revenue

Crescita Therapeutics had revenue of 4.09M CAD in the quarter ending June 30, 2024, a decrease of -20.81%. This brings the company's revenue in the last twelve months to 16.84M, down -22.84% year-over-year. In the year 2023, Crescita Therapeutics had annual revenue of 17.52M, down -25.52%.

• Revenue (ttm): 16.84M
• Revenue Growth: -22.84%
• P/S Ratio: 0.75
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 12.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	17.52M	-6.00M	-25.52%
Dec 31, 2022	23.53M	6.76M	40.29%
Dec 31, 2021	16.77M	1.13M	7.22%
Dec 31, 2020	15.64M	-6.70M	-29.98%
Dec 31, 2019	22.34M	5.71M	34.33%